Oral Session 3-8B ATL: Treatment

[OS3-8B-5] CCR4 mutations: A biomarker for high efficacy of mogamulizumab in adult T-cell leukemia/lymphoma

Yuma Sakamoto¹, Takashi Ishida^2,3, Ayako Masaki¹, Takayuki Murase¹, Kentaro Yonekura⁴, Yukie Tashiro⁵, Masahito Tokunaga⁶, Atae Utsunomiya⁶, Asahi Ito³, Shigeru Kusumoto³, Shinsuke Iida³, Ryuzo Ueda⁷, Hiroshi Inagaki¹ (1.Dept. Clin. Pathol., Nagoya City Univ., Sch. Med., 2.Hematol & Oncol, Iwate Medical Univ., Sch. Med., 3.Dept. Hematol., Nagoya City Univ., Sch. Med., 4.Dept. Dermatol., Imamura General Hosp., 5.Dept. Pathol., Imamura General Hosp., 6.Dept. Hematol., Imamura General Hosp., 7.Dept. Tumor Immunol, Aichi Medical Univ., Sch. Med.)